DRUG BINDING INTERFACES MAPPED TO 'TYROSINE-PROTEIN KINASE ABL1'
List of Binding Interfaces (Click on the entry ID to view details of interfaces and pattern clusters) (Note that ASSAM search use only 3-12 residue containing patterns)DrReposER ID | PDB | Ligand | Organism | Macromolecule | Pfam | Res. | Interface | HETATM |
---|---|---|---|---|---|---|---|---|
1OPJ_A_STIA3 | 1opj | STI DB00619(Imatinib) | Mus musculus | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 17 | LEU A 267TYR A 272VAL A 275ALA A 288LYS A 290GLU A 305VAL A 308MET A 309ILE A 312VAL A 318ILE A 332THR A 334PHE A 336MET A 337LEU A 389ALA A 399ASP A 400 | STI A 3 |
1OPJ_B_STIB4 | 1opj | STI DB00619(Imatinib) | Mus musculus | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU B 267TYR B 272VAL B 275ALA B 288LYS B 290GLU B 305VAL B 308MET B 309ILE B 312VAL B 318ILE B 332THR B 334PHE B 336MET B 337GLY B 340ARG B 381ALA B 399ASP B 400 | STI B 4 |
2GQG_A_1N1A501 | 2gqg | 1N1 DB01254(Dasatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 14 | LEU A 248TYR A 253ALA A 269LYS A 271GLU A 286MET A 290VAL A 299ILE A 313THR A 315PHE A 317MET A 318GLY A 321LEU A 370ALA A 380 | 1N1 A 501 |
2GQG_B_1N1B502 | 2gqg | 1N1 DB01254(Dasatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 14 | LEU B 248VAL B 256ALA B 269LYS B 271GLU B 286MET B 290VAL B 299ILE B 313THR B 315MET B 318TYR B 320GLY B 321LEU B 370ALA B 380 | 1N1 B 502 |
2HYY_A_STIA600 | 2hyy | STI DB00619(Imatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 18 | LEU A 248TYR A 253VAL A 256ALA A 269LYS A 271GLU A 286VAL A 289MET A 290ILE A 293VAL A 299ILE A 313THR A 315PHE A 317GLY A 321ARG A 362LEU A 370ALA A 380ASP A 381 | STI A 600 |
2HYY_B_STIB600 | 2hyy | STI DB00619(Imatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU B 248TYR B 253VAL B 256ALA B 269LYS B 271GLU B 286VAL B 289MET B 290ILE B 293VAL B 299ILE B 313THR B 315PHE B 317MET B 318GLY B 321LEU B 370ALA B 380ASP B 381 | STI B 600 |
2HYY_C_STIC600 | 2hyy | STI DB00619(Imatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU C 248TYR C 253VAL C 256ALA C 269LYS C 271GLU C 286VAL C 289MET C 290ILE C 293VAL C 299ILE C 313THR C 315PHE C 317MET C 318GLY C 321LEU C 370ALA C 380ASP C 381 | STI C 600 |
2HYY_D_STID600 | 2hyy | STI DB00619(Imatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 16 | LEU D 248TYR D 253VAL D 256ALA D 269LYS D 271GLU D 286MET D 290ILE D 293VAL D 299ILE D 313THR D 315PHE D 317MET D 318LEU D 370ALA D 380ASP D 381 | STI D 600 |
3CS9_A_NILA600 | 3cs9 | NIL DB04868(Nilotinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 22 | LEU A 248TYR A 253VAL A 256ALA A 269LYS A 271LYS A 285GLU A 286VAL A 289MET A 290ILE A 293LEU A 298VAL A 299ILE A 313THR A 315PHE A 317GLY A 321PHE A 359HIS A 361LEU A 370VAL A 379ALA A 380ASP A 381 | NIL A 600 |
3CS9_B_NILB600 | 3cs9 | NIL DB04868(Nilotinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 21 | LEU B 248TYR B 253VAL B 256ALA B 269LYS B 271GLU B 286VAL B 289MET B 290ILE B 293LEU B 298VAL B 299ILE B 313THR B 315GLY B 321PHE B 359HIS B 361LEU B 370VAL B 379ALA B 380ASP B 381PHE B 382 | NIL B 600 |
3CS9_C_NILC600 | 3cs9 | NIL DB04868(Nilotinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 21 | LEU C 248TYR C 253VAL C 256ALA C 269LYS C 271GLU C 286VAL C 289MET C 290ILE C 293LEU C 298VAL C 299ILE C 313THR C 315PHE C 317MET C 318PHE C 359HIS C 361VAL C 379ALA C 380ASP C 381PHE C 382 | NIL C 600 |
3CS9_D_NILD600 | 3cs9 | NIL DB04868(Nilotinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU D 248TYR D 253VAL D 256ALA D 269LYS D 271GLU D 286VAL D 289MET D 290ILE D 293LEU D 298THR D 315PHE D 317GLY D 321PHE D 359HIS D 361LEU D 370ALA D 380ASP D 381 | NIL D 600 |
3IK3_A_0LIA1 | 3ik3 | 0LI DB08901(Ponatinib) | Mus musculus | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 19 | LEU A 248TYR A 253ALA A 269LYS A 271GLU A 286VAL A 289MET A 290ILE A 293LEU A 298VAL A 299ILE A 313ILE A 315MET A 318HIS A 361ARG A 362LEU A 370ALA A 380ASP A 381PHE A 382 | 0LI A 1 |
3IK3_B_0LIB2 | 3ik3 | 0LI DB08901(Ponatinib) | Mus musculus | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 19 | LEU B 248TYR B 253ALA B 269LYS B 271GLU B 286VAL B 289MET B 290ILE B 293LEU B 298VAL B 299ILE B 313ILE B 315MET B 318HIS B 361ARG B 362LEU B 370ALA B 380ASP B 381PHE B 382 | 0LI B 2 |
3K5V_A_STIA2 | 3k5v | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 18 | LEU A 267TYR A 272VAL A 275ALA A 288LYS A 290GLU A 305VAL A 308MET A 309ILE A 312VAL A 318ILE A 332THR A 334PHE A 336MET A 337GLY A 340LEU A 389ALA A 399ASP A 400 | STI A 2 |
3K5V_B_STIB2 | 3k5v | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU B 267TYR B 272VAL B 275ALA B 288LYS B 290GLU B 305VAL B 308MET B 309ILE B 312VAL B 318ILE B 332THR B 334PHE B 336MET B 337GLY B 340LEU B 389ALA B 399ASP B 400 | STI B 2 |
3MS9_A_STIA1 | 3ms9 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 18 | LEU A 248TYR A 253VAL A 256ALA A 269LYS A 271GLU A 286VAL A 289MET A 290ILE A 293VAL A 299ILE A 313THR A 315PHE A 317MET A 318ARG A 362LEU A 370ALA A 380ASP A 381 | STI A 1 |
3MS9_B_STIB1 | 3ms9 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | no annotation | 19 | LEU B 248TYR B 253VAL B 256ALA B 269LYS B 271GLU B 286VAL B 289MET B 290ILE B 293VAL B 299ILE B 313THR B 315PHE B 317MET B 318GLY B 321ARG B 362LEU B 370ALA B 380ASP B 381 | STI B 1 |
3MSS_A_STIA1 | 3mss | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 18 | LEU A 248TYR A 253VAL A 256ALA A 269LYS A 271GLU A 286VAL A 289MET A 290ILE A 293VAL A 299ILE A 313THR A 315PHE A 317MET A 318ARG A 362LEU A 370ALA A 380ASP A 381 | STI A 1 |
3MSS_B_STIB1 | 3mss | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | no annotation | 19 | LEU B 248TYR B 253VAL B 256ALA B 269LYS B 271GLU B 286VAL B 289MET B 290ILE B 293VAL B 299ILE B 313THR B 315PHE B 317MET B 318GLY B 321ARG B 362LEU B 370ALA B 380ASP B 381 | STI B 1 |
3MSS_C_STIC1 | 3mss | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU C 248TYR C 253VAL C 256ALA C 269LYS C 271GLU C 286VAL C 289MET C 290ILE C 293VAL C 299ILE C 313THR C 315PHE C 317MET C 318ARG C 362LEU C 370ALA C 380ASP C 381 | STI C 1 |
3MSS_D_STID1 | 3mss | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU D 248TYR D 253VAL D 256ALA D 269LYS D 271GLU D 286VAL D 289MET D 290ILE D 293VAL D 299ILE D 313THR D 315PHE D 317MET D 318GLY D 321LEU D 370ALA D 380ASP D 381 | STI D 1 |
3OXZ_A_0LIA1 | 3oxz | 0LI DB08901(Ponatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 21 | LEU A 248TYR A 253ALA A 269LYS A 271GLU A 286VAL A 289MET A 290ILE A 293LEU A 298VAL A 299ILE A 313THR A 315MET A 318GLY A 321HIS A 361ARG A 362LEU A 370VAL A 379ALA A 380ASP A 381PHE A 382 | 0LI A 1 |
3UE4_A_DB8A601 | 3ue4 | DB8 DB06616(Bosutinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 12 | LEU A 248ALA A 269LYS A 271GLU A 286VAL A 299ILE A 313THR A 315PHE A 317MET A 318GLY A 321LEU A 370PHE A 382 | DB8 A 601 |
3UE4_B_DB8B601 | 3ue4 | DB8 DB06616(Bosutinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | no annotation | 14 | LEU B 248VAL B 256ALA B 269LYS B 271GLU B 286MET B 290VAL B 299ILE B 313THR B 315PHE B 317MET B 318GLY B 321LEU B 370PHE B 382 | DB8 B 601 |
4TWP_A_AXIA601 | 4twp | AXI DB06626(Axitinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 12 | LEU A 248TYR A 253VAL A 256ALA A 269LYS A 271PHE A 317MET A 318GLY A 321ASN A 368LEU A 370ALA A 380ASP A 381 | AXI A 601 |
4TWP_B_AXIB601 | 4twp | AXI DB06626(Axitinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | no annotation | 12 | LEU B 248TYR B 253VAL B 256ALA B 269LYS B 271PHE B 317MET B 318GLY B 321ASN B 368LEU B 370ALA B 380ASP B 381 | AXI B 601 |
4WA9_A_AXIA9000 | 4wa9 | AXI DB06626(Axitinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 11 | LEU A 248TYR A 253ALA A 269LYS A 271THR A 315MET A 318GLY A 321ASN A 368LEU A 370ALA A 380PHE A 382 | AXI A9000 |
4WA9_B_AXIB9000 | 4wa9 | AXI DB06626(Axitinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | no annotation | 12 | TYR B 253VAL B 256ALA B 269LYS B 271THR B 315PHE B 317MET B 318GLY B 321ASN B 368LEU B 370ALA B 380PHE B 382 | AXI B9000 |
4XEY_A_1N1A601 | 4xey | 1N1 DB01254(Dasatinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 15 | LEU A 267VAL A 275ALA A 288LYS A 290MET A 309VAL A 318ILE A 332THR A 334PHE A 336MET A 337GLY A 340LEU A 389ALA A 399ASP A 400PHE A 401 | 1N1 A 601 |
4XEY_B_1N1B601 | 4xey | 1N1 DB01254(Dasatinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | no annotation | 15 | LEU B 267VAL B 275ALA B 288LYS B 290MET B 309VAL B 318ILE B 332THR B 334PHE B 336MET B 337GLY B 340LEU B 389ALA B 399ASP B 400PHE B 401 | 1N1 B 601 |
5MO4_A_NILA601 | 5mo4 | NIL DB04868(Nilotinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 22 | LEU A 267TYR A 272VAL A 275ALA A 288LYS A 290GLU A 305VAL A 308MET A 309ILE A 312LEU A 317VAL A 318ILE A 332ILE A 334PHE A 336MET A 337GLY A 340PHE A 378HIS A 380LEU A 389ALA A 399ASP A 400PHE A 401 | NIL A 601 |
6HD4_A_STIA604 | 6hd4 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 17 | TYR A 272VAL A 275ALA A 288LYS A 290GLU A 305VAL A 308MET A 309ILE A 312VAL A 318ILE A 332THR A 334PHE A 336MET A 337GLY A 340LEU A 389ALA A 399ASP A 400 | STI A 604 |
6HD4_B_STIB602 | 6hd4 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | None | 18 | LEU B 267TYR B 272VAL B 275ALA B 288LYS B 290GLU B 305VAL B 308MET B 309ILE B 312VAL B 318ILE B 332THR B 334PHE B 336MET B 337GLY B 340LEU B 389ALA B 399ASP B 400 | STI B 602 |
6HD6_A_STIA603 | 6hd6 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 17 | LEU A 267TYR A 272VAL A 275ALA A 288LYS A 290GLU A 305MET A 309ILE A 312VAL A 318ILE A 332THR A 334PHE A 336MET A 337GLY A 340LEU A 389ALA A 399ASP A 400 | STI A 603 |
6HD6_B_STIB601 | 6hd6 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | None | 19 | LEU B 267TYR B 272VAL B 275ALA B 288LYS B 290GLU B 305VAL B 308MET B 309ILE B 312VAL B 318ILE B 332THR B 334PHE B 336MET B 337GLY B 340ARG B 381LEU B 389ALA B 399ASP B 400 | STI B 601 |